Colgate-Palmolive Company

WBAG:COLG Stock Report

Market Cap: €72.8b

Colgate-Palmolive Management

Management criteria checks 3/4

Colgate-Palmolive's CEO is Noel Wallace, appointed in Jul 2018, has a tenure of 6.42 years. total yearly compensation is $17.12M, comprised of 8.6% salary and 91.4% bonuses, including company stock and options. directly owns 0.046% of the company’s shares, worth €33.37M. The average tenure of the management team and the board of directors is 5.3 years and 5.7 years respectively.

Key information

Noel Wallace

Chief executive officer

US$17.1m

Total compensation

CEO salary percentage8.6%
CEO tenure6.4yrs
CEO ownership0.05%
Management average tenure5.3yrs
Board average tenure5.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Noel Wallace's remuneration changed compared to Colgate-Palmolive's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$3b

Jun 30 2024n/an/a

US$3b

Mar 31 2024n/an/a

US$3b

Dec 31 2023US$17mUS$1m

US$2b

Sep 30 2023n/an/a

US$2b

Jun 30 2023n/an/a

US$1b

Mar 31 2023n/an/a

US$2b

Dec 31 2022US$14mUS$1m

US$2b

Sep 30 2022n/an/a

US$2b

Jun 30 2022n/an/a

US$2b

Mar 31 2022n/an/a

US$2b

Dec 31 2021US$15mUS$1m

US$2b

Sep 30 2021n/an/a

US$3b

Jun 30 2021n/an/a

US$3b

Mar 31 2021n/an/a

US$3b

Dec 31 2020US$14mUS$1m

US$3b

Sep 30 2020n/an/a

US$3b

Jun 30 2020n/an/a

US$3b

Mar 31 2020n/an/a

US$3b

Dec 31 2019US$11mUS$1m

US$2b

Sep 30 2019n/an/a

US$2b

Jun 30 2019n/an/a

US$2b

Mar 31 2019n/an/a

US$2b

Dec 31 2018US$3mUS$891k

US$2b

Sep 30 2018n/an/a

US$2b

Jun 30 2018n/an/a

US$2b

Mar 31 2018n/an/a

US$2b

Dec 31 2017US$4mUS$821k

US$2b

Compensation vs Market: Noel's total compensation ($USD17.12M) is above average for companies of similar size in the Austrian market ($USD4.37M).

Compensation vs Earnings: Noel's compensation has been consistent with company performance over the past year.

CEO

Noel Wallace (60 yo)

6.4yrs

Tenure

US$17,121,584

Compensation

Mr. Noel R. Wallace serves as Chief Executive Officer and Director of Colgate-Palmolive Company since April 2, 2019 and has been its President since July 11, 2018. Mr. Wallace serves as Chairman of Colgate...

Leadership Team

NamePositionTenureCompensationOwnership
Noel Wallace
Chairman6.4yrsUS$17.12m0.046%
€ 33.4m
Stanley Sutula
Chief Financial Officer4.1yrsUS$5.69m0.0045%
€ 3.3m
Jennifer Daniels
Chief Legal Officer & Secretary10.1yrsUS$4.23m0.0079%
€ 5.7m
Panagiotis Tsourapas
Group President of Europe & Developing Markets5.3yrsUS$4.38m0.0075%
€ 5.5m
Prabha Parameswaran
Group President of Growth & Strategy5.3yrsUS$4.52m0.0062%
€ 4.5m
Stephan Habif
Chief Technology Officer2.3yrsno datano data
David Foster
Chief Information Officer1.9yrsno datano data
John Faucher
Chief Investor Relations Officer and Executive VP of M&Ano datano datano data
Kim Faulkner
Chief Ethics & Compliance Officerno datano datano data
Sally Massey
Chief Human Resources Officer4.9yrsno data0.0029%
€ 2.1m
Juan Zamorano
President of Latin America Division5.4yrsno datano data
Jean-Luc Fischer
President of Europe Division5.4yrsno datano data

5.3yrs

Average Tenure

59.5yo

Average Age

Experienced Management: COLG's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Noel Wallace
Chairman5.7yrsUS$17.12m0.046%
€ 33.4m
John Cahill
Independent Director19.2yrsUS$310.70k0.0040%
€ 2.9m
C. Harris
Independent Director8.8yrsUS$300.70k0.0026%
€ 1.9m
Lisa Edwards
Independent Director5.8yrsUS$300.25k0.0014%
€ 997.2k
Lorrie Norrington
Lead Independent Director9.3yrsUS$333.44k0.00013%
€ 94.6k
Martina Therese Hund-Mejean
Independent Director4.8yrsUS$310.94k0.00035%
€ 254.8k
Steven Cahillane
Independent Director1.8yrsUS$262.81k0.00025%
€ 182.0k
John Paul Bilbrey
Independent Director9.8yrsUS$310.70k0.00072%
€ 524.1k
Kimberly Nelson
Independent Director3.8yrsUS$308.44k0.0012%
€ 873.5k
Brian Newman
Independent Directorless than a yearno data0.000010%
€ 7.3k

5.7yrs

Average Tenure

63yo

Average Age

Experienced Board: COLG's board of directors are considered experienced (5.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 04:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Colgate-Palmolive Company is covered by 54 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher GrajaArgus Research Company
Edward LewisAtlantic Equities LLP
Ishan MajumdarBaptista Research